Statins lower pneumonia death risk in study

Share this article:
Cholestreol-lowering statin drugs can also reduce the risk of death by pneumonia in hospitalized patients, according to a study published this week in the journal Respiratory Research.
Researchers from the University of Texas Health Science Center at San Antonio found that pneumonia patients taking a cholesterol lowering statin such as Lipitor or Zocor when they entered the hospital were 2.8 times less likely to die from pneumonia than patients not taking the medications.
Statins are known to affect the immune system and that could explain their effect on pneumonia patients, the researchers speculated.
Pneumonia is the leading cause of death from infection in the United States, killing up to 40,000 people every year.
Share this article:

Email Newsletters

More in Business Briefs

Avastin pockets another Priority Review label

It's the second for this cancer drug in two weeks.

Court invalidates some healthcare subsidies

The lawsuit has been wending its way through the courts for a while, and, although it is being deliberated in several other venues, the decision is part of a legal dispute that puts patients in the 36 states offering federal exchanges in limbo.

FDA generic division overhaul kicks in

The Food and Drug Administration has been intent on elevating and reorganizing its office of Generic Drugs since 2012.